High Blood Pressure
Patients with retinal vein occlusions have increased mortality risk
Cardiac neuromodulation therapy drives reduction in BP
SAN FRANCISCO — Cardiac neuromodulation therapy resulted in significant reductions in systolic BP at 6 months in patients with persistent hypertension and an indication for a pacemaker, according to data from the MODERATO II study presented at TCT 2019.
Hypertension in pregnant women on the rise
Between 1970 and 2010, the rate of chronic hypertension among pregnant women rose from 0.11% to more than 1.5%, with advanced maternal age and year of delivery among the chief factors.
Treatment for high BP may slow cognitive decline in older patients
The treatment of high BP may slow down the advancement of cognitive decline, according to research presented at the American Heart Association’s Hypertension Scientific Sessions.
FDA: Actual risk from impurities in valsartan, losartan likely lower than published estimates
In a statement released today on safety issues with angiotensin II receptor blockers, the FDA wrote that risk for harm to patients from nitrosamine impurities is likely lower than has been stated in previous estimates, and that the risks of stopping the medications must be considered.
Neighborhood focus central to Cities Changing Diabetes program in Houston
HOUSTON — Beyond individuals, social, geographic and economic factors influence the risk for developing diabetes. By identifying specific factors on the local level, researchers are developing interventions to head off disease, according to two presenters at the American Association of Diabetes Educators annual meeting.